Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Equity (2020 - 2025)

Historic Return on Equity for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.2%.

  • Harmony Biosciences Holdings' Return on Equity changed 0.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.21% for FY2024, which is 600.0% down from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Return on Equity stood at 0.2%, which was down 0.0% from 0.2% recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Return on Equity peaked at 0.51% during Q3 2022, and registered a low of 0.08% during Q3 2021.
  • Moreover, its 5-year median value for Return on Equity was 0.2% (2025), whereas its average is 0.26%.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Return on Equity soared by 5700bps in 2021 and then tumbled by -2400bps in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Return on Equity (Quarter) stood at 0.18% in 2021, then surged by 166bps to 0.49% in 2022, then tumbled by -50bps to 0.24% in 2023, then fell by -23bps to 0.19% in 2024, then increased by 5bps to 0.2% in 2025.
  • Its last three reported values are 0.2% in Q3 2025, 0.2% for Q2 2025, and 0.18% during Q1 2025.